Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ACXP: Acurx Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ACXP
The Story
ACXP
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-108.8%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
3.78×
Acurx Pharmaceuticals, Inc.
ACXP
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Acurx Pharmaceuticals, Inc.
ACXP
NASDAQ
·
USD
·
Closed
$1.44
+1.41%
$1.44
+$0.02 (1.41%)
52W Range
2th
pctl
Volume
0.29×
avg
Mkt Cap
2.28M
USD
P/E
-0.3
TTM
Div Yield
–
ann
52W Range
2th
pctl
Volume
0.29×
avg
Market Cap
2.28M
USD
P/E Ratio
-0.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings